Search filters

List of works by Sophie Piperno-Neumann

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

scientific article published on 4 February 2016

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma

scientific article published on 03 September 2013

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

scientific article

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target

scientific article

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study

scientific article

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

scientific article

Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma

scientific article

Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases

scientific article

Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study

scientific article published on 16 November 2021

Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts

scientific article

Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).

scientific article

Patient-derived xenografts recapitulate molecular features of human uveal melanomas

scientific article

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

scientific article published on 24 February 2016

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

scientific article

Phase-II trials in osteosarcoma recurrences: A systematic review of past experience

scientific article

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study

scientific article

Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14).

scientific article published on April 2016

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

scientific article published on 07 February 2014

Results of 32 allograft-prosthesis composite reconstructions of the proximal femur

scientific article

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

SF3B1 mutations are associated with alternative splicing in uveal melanoma

scientific article published on 16 July 2013

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

scientific article published on 14 October 2016

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

scientific article published on 27 January 2012

Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts

scientific article (publication date: 2014)

The off-label use of targeted therapies in sarcomas: the OUTC'S program

scientific article

Therapeutic options in metastatic uveal melanoma

scientific article published on 21 October 2011

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

scientific article

Upcoming translational challenges for uveal melanoma

scientific article

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

scientific article

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

scientific article published on 17 June 2016